Lactose 625mg/5ml oral solution
Requires a prescription from a doctor or prescriber
A disaccharide of glucose and galactose in human and cow milk.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Clinical guidelines and formulary information
British National Formulary
Lactose
Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.
NICE clinical guidance(5)
Irritable bowel syndrome in adults: diagnosis and management (CG61)
Coeliac disease: recognition, assessment and management (NG20)
Irritable bowel syndrome in adults (QS114)
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & product information
Official product databases and supply status monitoring
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
4 targets
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Proteins and enzymes this drug interacts with in the body
In the nucleus: acts as a pre-mRNA splicing factor. Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells. Together with TRIM16, coordinates the recognition of membrane damage with mobilization of the core autophagy regulators ATG16L1 and BECN1 in response to damaged endomembranes
Involved compounds
Involved compounds
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Lactose
Additional database identifiers
Drugs Product Database (DPD)
6757
ChemSpider
389820
HUGO Gene Nomenclature Committee (HGNC)
HGNC:6563
GenAtlas
LGALS3
GeneCards
LGALS3
GenBank Gene Database
M57710
GenBank Protein Database
179531
UniProt Accession
LEG3_HUMAN
GenBank Gene Database
D01045
GenBank Protein Database
216784
UniProt Accession
NANH_MICVI
HUGO Gene Nomenclature Committee (HGNC)
HGNC:4298
GeneCards
GLB1
UniProt Accession
BGAL_HUMAN
GenBank Gene Database
J01636
GenBank Protein Database
146577
UniProt Accession
BGAL_ECOLI
HUGO Gene Nomenclature Committee (HGNC)
HGNC:23671
GeneCards
GLT6D1
UniProt Accession
GL6D1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:24867
GenAtlas
GLTP
GeneCards
GLTP
GenBank Gene Database
AF209704
GenBank Protein Database
6959686
UniProt Accession
GLTP_HUMAN
UniProt Accession
Q7SI98_STROI
GenBank Gene Database
M64551
UniProt Accession
XYNA_STRLI
DrugBank citations
If you use DrugBank data in your research, please cite the following publications: